OR WAIT null SECS
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Given the criticality of fill/finish processes, it is clear that automation is the next technological step.
April 12, 2023
Forecyte Bio has opened a new GMP facility in Shanghai just two months after its sister site in the United States.
The new site will include state-of-the-art cleanroom facilities, laboratories, R&D, and office spaces.
April 10, 2023
Webinar Date/Time: Friday, April 28, 2023 at 11am EDT | 10am CDT | 8am PDT
April 07, 2023
Claudio Fayad, VP of Technology, Process Systems, and Solutions discusses the intersection of automation and data security in the pharma industry.
Lonza and ABL Bio are collaborating on the development and manufacture of bispecific antibody product.
NextPharma has acquired a leading European chewable tablets manufacturing site from Takeda in Asker, Norway.
April 05, 2023
Nathan Pettus, president of Process Systems and Solutions at Emerson, discusses how automation is impacting recent sustainability technologies and solutions.
Sartorius’ acquisition of Polyplus is designed to strengthen its cell and gene therapy capabilities.
Interviews hosted on-site at the Emerson Automation Exchange in Grapevine, Texas, from October 24th to October 28th, 2022.
Mass spectrometric techniques are providing insights in critical RNA-based therapeutic areas.